South Africa takes G20 helm as polarisation complicates agenda
J&J vaccine study to resume in South Africa on Wednesday, ministry says
9:01 CAT | 26 Apr 2021
File photo: Reuters
A research study in South Africa further evaluating Johnson & Johnson’s Covid-19 vaccine in the field will resume on Wednesday, the health ministry said, after the study was paused over rare cases of blood clots in people given the vaccine.
During the pause, it had been established that there is a one in a million chance of getting a clot after the vaccine, so regulators across the world have recommended the continued use of J&J’s shot, the ministry said.
Local regulator SAHPRA, the South African Medical Research Council and health ministry have worked to ensure there is intensified pre-vaccination assessment and post-vaccination monitoring when the J&J study resumes, it added.
Source: Reuters
Show comments
Also read
Leave a Reply
Be the First to Comment!
You must be logged in to post a comment.
You must be logged in to post a comment.